These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 12934993)

  • 1. Nonalcoholic steatohepatitis: a possible side effect of atypical antipsychotics.
    Haberfellner EM; Honsig T
    J Clin Psychiatry; 2003 Jul; 64(7):851. PubMed ID: 12934993
    [No Abstract]   [Full Text] [Related]  

  • 2. Two new atypical antipsychotics: advantages and disadvantages.
    Lemon MD
    S D J Med; 1998 Aug; 51(8):285-6. PubMed ID: 9724957
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug review "surprises" reader.
    Shulman RW
    Can Fam Physician; 2000 Dec; 46():2381-3. PubMed ID: 11153401
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential risk of diabetes mellitus with the use of atypical antipsychotic medication.
    Dewan V
    Can J Psychiatry; 2003 Jun; 48(5):351-2. PubMed ID: 12866348
    [No Abstract]   [Full Text] [Related]  

  • 5. Antipsychotics during pregnancy.
    Littrell KH; Johnson CG; Peabody CD; Hilligoss N
    Am J Psychiatry; 2000 Aug; 157(8):1342. PubMed ID: 10910807
    [No Abstract]   [Full Text] [Related]  

  • 6. Should lipids be monitored during the first year of treatment with an atypical antipsychotic?
    Landry P; Benaliouad F
    Can J Psychiatry; 2003 Jun; 48(5):348-9. PubMed ID: 12866344
    [No Abstract]   [Full Text] [Related]  

  • 7. The value of atypical antipsychotics in the treatment of schizophrenia.
    Jessen LM
    Manag Care; 2002 Jul; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
    [No Abstract]   [Full Text] [Related]  

  • 8. Olanzapine.
    Hale AS
    Br J Hosp Med; 1997 Nov 5-18; 58(9):442-5. PubMed ID: 9619205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine and NMS.
    Hickey C; Stewart C; Lippmann S
    Psychiatr Serv; 1999 Jun; 50(6):836-7. PubMed ID: 10375159
    [No Abstract]   [Full Text] [Related]  

  • 10. Fungal dermatitis with olanzapine in schizophrenia.
    Fogl T; Margolese HC
    Can J Psychiatry; 2003 Oct; 48(9):643-4. PubMed ID: 14631890
    [No Abstract]   [Full Text] [Related]  

  • 11. Side effects of olanzapine.
    Wahid Z; Ali S
    Am J Psychiatry; 1999 May; 156(5):800-1. PubMed ID: 10327927
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevation of prolactin levels by atypical antipsychotics.
    Turrone P; Kapur S; Seeman MV; Flint AJ
    Am J Psychiatry; 2002 Jan; 159(1):133-5. PubMed ID: 11772702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine-induced agranulocytosis.
    Naumann R; Felber W; Heilemann H; Reuster T
    Lancet; 1999 Aug; 354(9178):566-7. PubMed ID: 10470705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supersensitivity psychosis in patients with schizophrenia after sudden olanzapine withdrawal.
    Llorca PM; Vaiva G; Lancon C
    Can J Psychiatry; 2001 Feb; 46(1):87-8. PubMed ID: 11221497
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypersalivation coincident with olanzapine treatment.
    Perkins DO; McClure RK
    Am J Psychiatry; 1998 Jul; 155(7):993-4. PubMed ID: 9659875
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid onset of dyskinesia induced by olanzapine.
    Yeh IN; Lin SK; Tsai CJ; Liu HC
    Psychiatry Clin Neurosci; 2003 Dec; 57(6):605-6. PubMed ID: 14629710
    [No Abstract]   [Full Text] [Related]  

  • 17. Olanzapine-induced somnambulism.
    Kolivakis TT; Margolese HC; Beauclair L; Chouinard G
    Am J Psychiatry; 2001 Jul; 158(7):1158. PubMed ID: 11431244
    [No Abstract]   [Full Text] [Related]  

  • 18. Olanzapine-induced obsessive-compulsive disorder.
    Mottard JP; de la Sablonnière JF
    Am J Psychiatry; 1999 May; 156(5):799-800. PubMed ID: 10327925
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse events related to olanzapine.
    Conley RR; Meltzer HY
    J Clin Psychiatry; 2000; 61 Suppl 8():26-9; discussion 30. PubMed ID: 10811240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia.
    Ritchie CW; Chiu E; Harrigan S; Hall K; Hassett A; Macfarlane S; Mastwyk M; O'Connor DW; Opie J; Ames D
    Int J Geriatr Psychiatry; 2003 May; 18(5):432-40. PubMed ID: 12766921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.